tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Cynata’s CYP-001 Approval Pathway Unaffected by Ryoncil® Exclusivity
PremiumCompany AnnouncementsCynata’s CYP-001 Approval Pathway Unaffected by Ryoncil® Exclusivity
3M ago
Cynata Therapeutics Hosts Investor Webinar to Highlight Clinical Advancements
Premium
Company Announcements
Cynata Therapeutics Hosts Investor Webinar to Highlight Clinical Advancements
3M ago
Cynata Therapeutics Advances Clinical Trials with Promising Developments
Premium
Company Announcements
Cynata Therapeutics Advances Clinical Trials with Promising Developments
4M ago
Cynata Therapeutics Showcases at Advanced Therapies Congress 2025
PremiumCompany AnnouncementsCynata Therapeutics Showcases at Advanced Therapies Congress 2025
5M ago
Cynata Therapeutics Engages Investors at Euroz Hartleys Conference
Premium
Company Announcements
Cynata Therapeutics Engages Investors at Euroz Hartleys Conference
5M ago
Cynata Therapeutics Reports Financial Results for Half-Year Ending December 2024
Premium
Company Announcements
Cynata Therapeutics Reports Financial Results for Half-Year Ending December 2024
5M ago
Cynata’s iPSC-derived MSCs Show Superior Therapeutic Potential
PremiumCompany AnnouncementsCynata’s iPSC-derived MSCs Show Superior Therapeutic Potential
6M ago
Cynata Therapeutics to Showcase Cymerus™ Technology at Euroz Hartleys Forum
Premium
Company Announcements
Cynata Therapeutics to Showcase Cymerus™ Technology at Euroz Hartleys Forum
6M ago
Cynata Therapeutics Advances Clinical Trials and Strengthens Financial Position
Premium
Company Announcements
Cynata Therapeutics Advances Clinical Trials and Strengthens Financial Position
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100